Albireo: Ipsen concludes purchase of Albireo Pharma
Ipsen expects the acquisition will strengthen its portfolio in rare diseases, as well as the treatment for cholestatic-liver diseases. The post Ipsen concludes purchase of Albireo Pharma appeared first on Pharmaceutical Technology.
Read full article »
Albireo is a Massachusetts-based biopharmaceutical firm that researches and develops novel bile acid modulators for the treatment of liver diseases.
Read more